相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。LDL Apheresis and Lp (a) Apheresis: A Clinician's Perspective
Meral Kayikcioglu
CURRENT ATHEROSCLEROSIS REPORTS (2021)
Existing and emerging therapies for the treatment of familial hypercholesterolemia
Robert S. Rosenson
JOURNAL OF LIPID RESEARCH (2021)
Lipoprotein metabolism in familial hypercholesterolemia
Kevin Chemello et al.
JOURNAL OF LIPID RESEARCH (2021)
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
Antonio J. Vallejo-Vaz et al.
LANCET (2021)
Impulsivity and Compulsivity and Their Relationship with Non-Adherence to Treatment in the Prison Population
Francisca Lopez-Torrecillas et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Familial Hypercholesterolemia: Global Burden and Approaches
Lale Tokgozoglu et al.
CURRENT CARDIOLOGY REPORTS (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)
Ozlem Kuman Tuncel et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2020)
Lipoprotein (a) predicts recurrent worse outcomes in type 2 diabetes mellitus patients with prior cardiovascular events: a prospective, observational cohort study
Yan Zhang et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)
James A. Underberg et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2020)
Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)
Meral Kayikcioglu et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)
Meral Kayikcioglu et al.
ATHEROSCLEROSIS (2018)
Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
Dirk J. Blom et al.
CIRCULATION (2017)
Management of homozygous familial hypercholesterolemia in real-world clinical practice: A report of 7 Italian patients treated in Rome with lomitapide and Lipoprotein apheresis
Claudia Stefanutti et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Long-term follow-up of patients with homozygous familial hypercholesterolemia; A 13-year experience of a university hospital lipid clinic
Meral Kayikcioglu et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2014)
The global prevalence of dementia: A systematic review and metaanalysis
Martin Prince et al.
ALZHEIMERS & DEMENTIA (2013)
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
Marina Cuchel et al.
LANCET (2013)
Short Form of Barratt Impulsiveness Scale (BIS-11-SF) Turkish Adaptation Study
Lut Tamam et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY (2013)
Multiple functions of microsomal triglyceride transfer protein
M. Mahmood Hussain et al.
NUTRITION & METABOLISM (2012)
Biological, clinical and population relevance of 95 loci for blood lipids
Tanya M. Teslovich et al.
NATURE (2010)